Krystal Biotech Receives FDA Platform Technology Designation for HSV-1 Viral Vector Used in KB801 for the Treatment of Neurotrophic Keratitis

#KrystalBiotech Receives #FDAPlatformTechnologyDesignation for HSV-1 Viral Vector Used in KB801 for the Treatment of #NeurotrophicKeratitis

KB801 has the potential to significantly reduce treatment burden & maintain consistent NGF levels.

www.biospace.com/press-releas...